Virtu KCG Holdings’s Loxo Oncology, Inc LOXO Stock Holding History

Virtu KCG Holdings’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,177	Closed	-$230K	–	4050
2016 Q4	$230K	Buy	+7,177	New	+$184K	0.01%	2416

Other funds holding LOXO

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu KCG Holdings's LOXO Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Loxo Oncology, Inc (LOXO) in Q1 2017, closing a stake of 7,177 shares — an estimated $230K sold.

Virtu KCG Holdings first reported a position in LOXO in Q4 2016 and held it in 1 quarter. The position peaked at $230K in Q4 2016. 86 funds tracked by Wall St. Rank hold LOXO as of Q1 2017.

Virtu KCG Holdings reported no remaining Loxo Oncology, Inc position as of Q1 2017 after selling out during the quarter.
Virtu KCG Holdings sold 7,177 Loxo Oncology, Inc shares in Q1 2017, an estimated $230K.
Virtu KCG Holdings first reported a position in Loxo Oncology, Inc in Q4 2016 and held it in 1 quarter.
Virtu KCG Holdings's Loxo Oncology, Inc position peaked at $230K in Q4 2016.
86 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.